tlooto
회원가입
Open AccessMedicine

Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease

H. Iwaki, N. Nishikawa, M. Nagai, T. Tsujii, H. Yabe, M. Kubo, I. Ieiri, M. Nomoto

2015.3.1Neurology and Clinical Neuroscience

DOI: 10.1111/ncn3.152

tlooto Summary

There are two formulations oflevodopa in Japan and a few other countries, levodopa/benserazide 100/25 mg and levodOPA/carbidopa 100/10 mg, which have been generally regarded as interchangeable in Parkinson's disease treatment.

초록

There are two formulations of levodopa in Japan and a few other countries, levodopa/benserazide 100/25 mg and levodopa/carbidopa 100/10 mg, which have been generally regarded as interchangeable in Parkinson's disease treatment.

인용 형식

IWAKI, H., et al. Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with parkinson's disease. Neurology and Clinical Neuroscience, 2015, 3.